We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Helix BioMedix is a preclinical biopharmaceutical company focused on drug development for treatment of rare dermatological diseases, such as xeroderma pigmentosum. Our legacy R&D consists of an extensive proprietary library of patented bioactive peptides based on the body's innate immunity many of w... Helix BioMedix is a preclinical biopharmaceutical company focused on drug development for treatment of rare dermatological diseases, such as xeroderma pigmentosum. Our legacy R&D consists of an extensive proprietary library of patented bioactive peptides based on the body's innate immunity many of which the company has outlicensed to partners to commercialize. Helix BioMedix, Inc., is committed to building long term shareholder value through development of novel drugs for rare dermatological conditions with unmet needs and strategic management of our diverse peptide library. Show more
Fri, Jun 28, 2013 12:00 - Helix BioMedix, Inc. (HXBM: OTC Pink Limited) - Tier Change - The symbol, HXBM, no longer is classified as OTC Pink Limited. As of Fri, Jun 28, 2013, HXBM resides in the...
Fri, Feb 01, 2013 12:00 - Helix BioMedix, Inc. (HXBMD: OTC Link) - Symbol Change - The symbol, HXBMD, is no longer a valid symbol for Helix BioMedix, Inc.. As of Fri, Feb 01, 2013, the new...
Thu, Jan 03, 2013 12:00 - Helix BioMedix, Inc. (HXBM: OTC Link) - Deleted Symbol - As of Thu, Jan 03, 2013, HXBM is no longer a valid symbol. You may find a complete list of deleted symbols at...
Wed, Jan 02, 2013 08:00 - Helix BioMedix, Inc. (HXBM: OTC Link) - Ex-Dividend - As of Thu, Jan 03, 2013, Helix BioMedix, Inc. traded ex-dividend. Helix BioMedix, Inc. will disburse a Reverse...
Wed, Jan 02, 2013 08:00 - Helix BioMedix, Inc. (HXBM: OTC Link) - Scheduled Ex-Dividend - Helix BioMedix, Inc. has announced a dividend ex-date for (HXBM: OTC Link). Helix BioMedix, Inc. is...
Helix BioMedix, Inc. (OTCQB: HXBM), a developer of bioactive peptides, today announced financial results for the third quarter ended September 30, 2012. Third Quarter 2012...
Helix BioMedix, Inc. (OTCQB: HXBM) (the “Company”), a developer of bioactive peptides, today announced that it has filed a Schedule 13E-3 and related preliminary proxy statement...
Helix BioMedix, Inc. (OTCQB: HXBM), a developer of bioactive peptides, today announced financial results for the second quarter ended June 30, 2012. Second Quarter 2012...
Helix BioMedix, Inc. (OTCQB: HXBM), a developer of bioactive peptides, today announced financial results for the first quarter ended March 31, 2012. First Quarter 2012...
Helix BioMedix, Inc. (OTCQB: HXBM), a developer of bioactive peptides, today announced financial results for the year ended December 31, 2011. 2011 Financial and Business...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 12 | 12 | 12 | 108 | 12 | CS |
4 | 0 | 0 | 12 | 12 | 12 | 108 | 12 | CS |
12 | -6 | -33.3333333333 | 18 | 18 | 12 | 165 | 14.88753799 | CS |
26 | -11.5 | -48.9361702128 | 23.5 | 23.5 | 12 | 147 | 17.00831919 | CS |
52 | -11.27 | -48.4314568113 | 23.27 | 23.5 | 12 | 131 | 18.93102353 | CS |
156 | -9.99999999998E-5 | -0.000833326388945 | 12.0001 | 26 | 12 | 195 | 20.44023439 | CS |
260 | -29.2 | -70.8737864078 | 41.2 | 41.2 | 12 | 220 | 23.90050003 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions